The lead program in the collaboration is a once-monthly GLP-1 receptor agonist product candidate that will initially target obesity and type 2 diabetes
Clients who receive B12 shots for energy report feeling noticeably more alert, focused, and activeoften within 24-48 hours
Ivania Rizo notes, gastrointestinal side effects are common with GLP-1 medications, and having a support system can be invaluable when using low dose semaglutide for maintenance during this process
*Correspondence: Yongye Huang, [email protected] This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Cell and Developmental Biology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
In cell models overexpressing mHTT, liraglutide restored insulin signaling, activated AMPK, upregulated antioxidant responses, and enhanced autophagy, reducing aggregate burden and improving viability (172)